India's Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
Sun Pharma received South African regulatory approval to manufacture and sell a generic version of semaglutide, challenging Novo Nordisk and Eli Lilly in the diabetes and obesity drug market.
reuters · 2026-07-15 08:06 UTC